Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Navnath S Gavande

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Drug Discovery Today|September 3, 2023
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategyKetki Bhise, Navnath S Gavande, Arun K Iyer
Drug Discovery Today|March 5, 2022
Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancerDisha Iyengar, Katyayani Tatiparti, Navnath S Gavande, et al.
Chemmedchem|September 2, 2022
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage ResponseDiana Ainembabazi, Xinran Geng, Navnath S Gavande, et al.
ACS Chemical Biology|December 7, 2017
Modulating DNA Repair Pathways to Improve Precision Genome EngineeringKatherine S Pawelczak, Navnath S Gavande, Pamela S VanderVere-Carozza, et al.
Bioorganic Chemistry|January 17, 2021
Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibitionGaurav Joshi, Manisha Sharma, Sourav Kalra, et al.
Basic & Clinical Pharmacology & Toxicology|December 17, 2009
Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed ratsSrinivas Nammi, Moon S Kim, Navnath S Gavande, et al.
Drug Discovery Today|August 3, 2024
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
The Journal of Biological Chemistry|December 3, 2014
Characterization of a Drosophila ortholog of the Cdc7 kinase: a role for Cdc7 in endoreplication independent of ChiffonRobert Stephenson, Marcus R Hosler, Navnath S Gavande, et al.
Molecular Cancer|March 29, 2023
PROTAC'ing oncoproteins: targeted protein degradation for cancer therapyJeremy M Kelm, Deepti S Pandey, Evan Malin, et al.
Journal of Medicinal Chemistry|September 22, 2017
Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA InteractionNavnath S Gavande, Pamela VanderVere-Carozza, Akaash K Mishra, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Drug Discovery Today|September 3, 2023
Leveraging hypoxia in triple-negative breast cancer as a promising treatment strategyKetki Bhise, Navnath S Gavande, Arun K Iyer
Drug Discovery Today|March 5, 2022
Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancerDisha Iyengar, Katyayani Tatiparti, Navnath S Gavande, et al.
Chemmedchem|September 2, 2022
Synthesis and Biological Evaluation of Cardiac Glycosides for Cancer Therapy by Targeting the DNA Damage ResponseDiana Ainembabazi, Xinran Geng, Navnath S Gavande, et al.
ACS Chemical Biology|December 7, 2017
Modulating DNA Repair Pathways to Improve Precision Genome EngineeringKatherine S Pawelczak, Navnath S Gavande, Pamela S VanderVere-Carozza, et al.
Bioorganic Chemistry|January 17, 2021
Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibitionGaurav Joshi, Manisha Sharma, Sourav Kalra, et al.
Basic & Clinical Pharmacology & Toxicology|December 17, 2009
Regulation of low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase expression by Zingiber officinale in the liver of high-fat diet-fed ratsSrinivas Nammi, Moon S Kim, Navnath S Gavande, et al.
Drug Discovery Today|August 3, 2024
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2Tom Lucaj, Ian Hay, Amirreza Samarbakhsh, et al.
The Journal of Biological Chemistry|December 3, 2014
Characterization of a Drosophila ortholog of the Cdc7 kinase: a role for Cdc7 in endoreplication independent of ChiffonRobert Stephenson, Marcus R Hosler, Navnath S Gavande, et al.
Molecular Cancer|March 29, 2023
PROTAC'ing oncoproteins: targeted protein degradation for cancer therapyJeremy M Kelm, Deepti S Pandey, Evan Malin, et al.
Journal of Medicinal Chemistry|September 22, 2017
Design and Structure-Guided Development of Novel Inhibitors of the Xeroderma Pigmentosum Group A (XPA) Protein-DNA InteractionNavnath S Gavande, Pamela VanderVere-Carozza, Akaash K Mishra, et al.
Pageof 3